Producing organism:

Lysobacter sp. BMK333-48F3



Clinical use:


Class no:

5 Reference(s)

Search PubMed »

Please scroll horizontally.

Title Author Journal Year Volume Page
Tripropeptins, novel antimicrobial agents produced by Lysobacter sp. I. Taxonomy, isolation and biological activities. H. Hashizume; M. Igarashi; S. Hattori; M. Hori; M. Hamada; T. Takeuchi J. Antibiotics 2001 54 1054-1059
Tripropeptins, novel antimicrobial agents produced by Lysobacter sp. II. Structure elucidation. H. Hashizume; S. Hirosawa; R. Sawa; Y. Muraoka; D. Ikeda; H. Naganawa; M. Igarashi J. Antibiotics 2004 57 52-58
Tripropeptin E, a new tripropeptin group antibiotic produced by Lysobacter sp. BMK333-48F3. H. Hashizume; S. Hattori; M. Igarashi; Y. Akamatsu J. Antibiotics 2004 57 394-399
Production of tripropeptins in media supplemented with precursors based on the biosynthetic pathway. H. Hashizume, C. Nosaka, S. Hirosawa, M. Igarashi, Y. Nishimura, and Y. Akamatsu ARKIVOC 2007 241-253
A New Type of Tripropeptin with Anteiso-branched Chain Fatty Acid from Lysobacter sp. BMK333-48F3 H. Hashizume, M. Igarashi, R. Sawa, H. Adachi, Y. Nishimura, Y. & Y. Akamatsu J. Antibiotics 2008 61 577-582
Tripropeptin C blocks the lipid cycle of cell wall biosynthesis by complex formation with undecaprenyl pyrophosphate. H. Hashizume, R. Sawa, S. Harada, M. Igarashi, H. Adachi, Y. Nishimura & A. Nomoto. Antimicrob. Agents Chemother. 2011 55 3821-3828
Studies for the development of novel anti-MRSA/VRE drugs. H. Hashizume. Yakugaku Zasshi 2012 132 (1) 59-67.